These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 19095782

  • 1. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
    Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, Nishie A, Hirakawa M, Ushijima Y, Okamoto D, Taketomi A, Honda H.
    Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
    [Abstract] [Full Text] [Related]

  • 2. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker.
    Choi JW, Lee JM, Kim SJ, Yoon JH, Baek JH, Han JK, Choi BI.
    Radiology; 2013 Jun; 267(3):776-86. PubMed ID: 23401584
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH, Lee JM, Baek JH, Shin CI, Han JK, Choi BI.
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [Abstract] [Full Text] [Related]

  • 4. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T.
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinoma with indeterminate or false-negative findings at initial MR imaging: effect on eligibility for curative treatment initial observations.
    Choi D, Mitchell DG, Verma SK, Bergin D, Navarro VJ, Malliah AB, McGowan C, Hann HW, Herrine SK.
    Radiology; 2007 Sep; 244(3):776-83. PubMed ID: 17690322
    [Abstract] [Full Text] [Related]

  • 6. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
    Yu MH, Kim JH, Yoon JH, Kim HC, Chung JW, Han JK, Choi BI.
    Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
    [Abstract] [Full Text] [Related]

  • 7. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
    Hecht EM, Holland AE, Israel GM, Hahn WY, Kim DC, West AB, Babb JS, Taouli B, Lee VS, Krinsky GA.
    Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
    [Abstract] [Full Text] [Related]

  • 8. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.
    Invest Radiol; 2009 Dec; 44(12):800-7. PubMed ID: 19838119
    [Abstract] [Full Text] [Related]

  • 9. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH, Kim SH, Park MJ, Park CK, Rhim H.
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [Abstract] [Full Text] [Related]

  • 10. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging predicts the histological grade of hepatocellular carcinoma only in patients with Child-Pugh class A cirrhosis.
    Kim HY, Choi JY, Kim CW, Bae SH, Yoon SK, Lee YJ, Rha SE, You YK, Kim DG, Jung ES.
    Liver Transpl; 2012 Jul; 18(7):850-7. PubMed ID: 22407909
    [Abstract] [Full Text] [Related]

  • 11. Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.
    Ahn SS, Kim MJ, Lim JS, Hong HS, Chung YE, Choi JY.
    Radiology; 2010 May; 255(2):459-66. PubMed ID: 20413759
    [Abstract] [Full Text] [Related]

  • 12. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acid-enhanced and diffusion-weighted MR imaging patterns.
    Park MJ, Kim YK, Lee MW, Lee WJ, Kim YS, Kim SH, Choi D, Rhim H.
    Radiology; 2012 Sep; 264(3):761-70. PubMed ID: 22843769
    [Abstract] [Full Text] [Related]

  • 13. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M, Marin D, Guerrisi A, Baski M, Galati F, Rossi M, Brozzetti S, Masciangelo R, Passariello R, Catalano C.
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [Abstract] [Full Text] [Related]

  • 14. Hepatocellular carcinoma in liver transplantation candidates: detection with gadobenate dimeglumine-enhanced MRI.
    Choi SH, Lee JM, Yu NC, Suh KS, Jang JJ, Kim SH, Choi BI.
    AJR Am J Roentgenol; 2008 Aug; 191(2):529-36. PubMed ID: 18647927
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
    Kim BS, Hayashi PH, Kim SH, Angthong W, Srirattanapong S, Woosley JT, Semelka RC.
    Radiology; 2013 Jul; 268(1):109-19. PubMed ID: 23392426
    [Abstract] [Full Text] [Related]

  • 16. Hepatocellular carcinoma in patients with cirrhosis: qualitative comparison of gadobenate dimeglumine-enhanced MR imaging and multiphasic 64-section CT.
    Marin D, Di Martino M, Guerrisi A, De Filippis G, Rossi M, Ginanni Corradini S, Masciangelo R, Catalano C, Passariello R.
    Radiology; 2009 Apr; 251(1):85-95. PubMed ID: 19332848
    [Abstract] [Full Text] [Related]

  • 17. Using Gd-EOB-DTPA-enhanced 3-T MRI for the differentiation of infiltrative hepatocellular carcinoma and focal confluent fibrosis in liver cirrhosis.
    Park YS, Lee CH, Kim BH, Lee J, Choi JW, Kim KA, Ahn JH, Park CM.
    Magn Reson Imaging; 2013 Sep; 31(7):1137-42. PubMed ID: 23688409
    [Abstract] [Full Text] [Related]

  • 18. Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.
    Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, Koda W, Kozaka K, Yoneda N, Yamashita T, Kaneko S, Nakanuma Y.
    Radiology; 2010 Sep; 256(3):817-26. PubMed ID: 20663969
    [Abstract] [Full Text] [Related]

  • 19. Gadoxetate disodium-enhanced MR imaging: differentiation between early-enhancing non-tumorous lesions and hypervascular hepatocellular carcinomas.
    Goshima S, Kanematsu M, Watanabe H, Kondo H, Mizuno N, Kawada H, Shiratori Y, Onozuka M, Moriyama N, Bae KT.
    Eur J Radiol; 2011 Aug; 79(2):e108-12. PubMed ID: 21592707
    [Abstract] [Full Text] [Related]

  • 20. Detection of hepatocellular carcinoma in gadoxetic acid-enhanced MRI and diffusion-weighted MRI with respect to the severity of liver cirrhosis.
    Kim AY, Kim YK, Lee MW, Park MJ, Hwang J, Lee MH, Lee JW.
    Acta Radiol; 2012 Oct 01; 53(8):830-8. PubMed ID: 22847903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.